Concepedia

Publication | Closed Access

A Placebo‐Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa‐Induced Dyskinesia

34

Citations

31

References

2016

Year

Abstract

AQW051 did not significantly reduce dyskinesia or parkinsonian severity. © 2016 International Parkinson and Movement Disorder Society.

References

YearCitations

Page 1